Global Placental Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Placental Stem Cell Therapy market size was valued at USD 860.2 million in 2023 and is forecast to a readjusted size of USD 1406.2 million by 2030 with a CAGR of 7.3% during review period.

Placental stem cells are cells derived from the placental blood and other body fluids of a new-born baby. Stem cells are human cells classified into a different variety of cell types, including brain and muscle cells. Stem cells are sometimes used in the development of regenerative therapies. Regenerative medicine represents a category of scientific alternatives to stem cell therapy (such as tissue regeneration). These treatments include the capacity to regenerate human cells, tissues, or organs to return the body to healthy working. Stem cell therapies are used to cure and improve diseases like spinal cord injuries, Parkinson's disease, heart disease, and diabetes.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Placental Stem Cell Therapy industry chain, the market status of Hospitals and Specialty Clinics (Hematologic Malignancies and Disorders, Congenital Immunodeficiency Disorders), Clinical Research Organizations (Hematologic Malignancies and Disorders, Congenital Immunodeficiency Disorders), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Placental Stem Cell Therapy.

Regionally, the report analyzes the Placental Stem Cell Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Placental Stem Cell Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Placental Stem Cell Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Placental Stem Cell Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Hematologic Malignancies and Disorders, Congenital Immunodeficiency Disorders).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Placental Stem Cell Therapy market.

Regional Analysis: The report involves examining the Placental Stem Cell Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Placental Stem Cell Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Placental Stem Cell Therapy:
Company Analysis: Report covers individual Placental Stem Cell Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Placental Stem Cell Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Specialty Clinics, Clinical Research Organizations).

Technology Analysis: Report covers specific technologies relevant to Placental Stem Cell Therapy. It assesses the current state, advancements, and potential future developments in Placental Stem Cell Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Placental Stem Cell Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Placental Stem Cell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Hematologic Malignancies and Disorders
    Congenital Immunodeficiency Disorders
    Metabolic Disorders
    Neurological Disorders
    Others

Market segment by Application
    Hospitals and Specialty Clinics
    Clinical Research Organizations
    Research Institutes and Academies
    Others

Market segment by players, this report covers
    Lifebank Stem Cell Banking
    Cynata
    Celularity
    Athersys
    Americord Registry
    ReNeuron Group
    ReeLabs
    Mesoblast
    Pluristem Therapeutics

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Placental Stem Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Placental Stem Cell Therapy, with revenue, gross margin and global market share of Placental Stem Cell Therapy from 2019 to 2024.
Chapter 3, the Placental Stem Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Placental Stem Cell Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Placental Stem Cell Therapy.
Chapter 13, to describe Placental Stem Cell Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Placental Stem Cell Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Placental Stem Cell Therapy by Type
        1.3.1 Overview: Global Placental Stem Cell Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Placental Stem Cell Therapy Consumption Value Market Share by Type in 2023
        1.3.3 Hematologic Malignancies and Disorders
        1.3.4 Congenital Immunodeficiency Disorders
        1.3.5 Metabolic Disorders
        1.3.6 Neurological Disorders
        1.3.7 Others
    1.4 Global Placental Stem Cell Therapy Market by Application
        1.4.1 Overview: Global Placental Stem Cell Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals and Specialty Clinics
        1.4.3 Clinical Research Organizations
        1.4.4 Research Institutes and Academies
        1.4.5 Others
    1.5 Global Placental Stem Cell Therapy Market Size & Forecast
    1.6 Global Placental Stem Cell Therapy Market Size and Forecast by Region
        1.6.1 Global Placental Stem Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Placental Stem Cell Therapy Market Size by Region, (2019-2030)
        1.6.3 North America Placental Stem Cell Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe Placental Stem Cell Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Placental Stem Cell Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America Placental Stem Cell Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Placental Stem Cell Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Lifebank Stem Cell Banking
        2.1.1 Lifebank Stem Cell Banking Details
        2.1.2 Lifebank Stem Cell Banking Major Business
        2.1.3 Lifebank Stem Cell Banking Placental Stem Cell Therapy Product and Solutions
        2.1.4 Lifebank Stem Cell Banking Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Lifebank Stem Cell Banking Recent Developments and Future Plans
    2.2 Cynata
        2.2.1 Cynata Details
        2.2.2 Cynata Major Business
        2.2.3 Cynata Placental Stem Cell Therapy Product and Solutions
        2.2.4 Cynata Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Cynata Recent Developments and Future Plans
    2.3 Celularity
        2.3.1 Celularity Details
        2.3.2 Celularity Major Business
        2.3.3 Celularity Placental Stem Cell Therapy Product and Solutions
        2.3.4 Celularity Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Celularity Recent Developments and Future Plans
    2.4 Athersys
        2.4.1 Athersys Details
        2.4.2 Athersys Major Business
        2.4.3 Athersys Placental Stem Cell Therapy Product and Solutions
        2.4.4 Athersys Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Athersys Recent Developments and Future Plans
    2.5 Americord Registry
        2.5.1 Americord Registry Details
        2.5.2 Americord Registry Major Business
        2.5.3 Americord Registry Placental Stem Cell Therapy Product and Solutions
        2.5.4 Americord Registry Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Americord Registry Recent Developments and Future Plans
    2.6 ReNeuron Group
        2.6.1 ReNeuron Group Details
        2.6.2 ReNeuron Group Major Business
        2.6.3 ReNeuron Group Placental Stem Cell Therapy Product and Solutions
        2.6.4 ReNeuron Group Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 ReNeuron Group Recent Developments and Future Plans
    2.7 ReeLabs
        2.7.1 ReeLabs Details
        2.7.2 ReeLabs Major Business
        2.7.3 ReeLabs Placental Stem Cell Therapy Product and Solutions
        2.7.4 ReeLabs Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 ReeLabs Recent Developments and Future Plans
    2.8 Mesoblast
        2.8.1 Mesoblast Details
        2.8.2 Mesoblast Major Business
        2.8.3 Mesoblast Placental Stem Cell Therapy Product and Solutions
        2.8.4 Mesoblast Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Mesoblast Recent Developments and Future Plans
    2.9 Pluristem Therapeutics
        2.9.1 Pluristem Therapeutics Details
        2.9.2 Pluristem Therapeutics Major Business
        2.9.3 Pluristem Therapeutics Placental Stem Cell Therapy Product and Solutions
        2.9.4 Pluristem Therapeutics Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Pluristem Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Placental Stem Cell Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Placental Stem Cell Therapy by Company Revenue
        3.2.2 Top 3 Placental Stem Cell Therapy Players Market Share in 2023
        3.2.3 Top 6 Placental Stem Cell Therapy Players Market Share in 2023
    3.3 Placental Stem Cell Therapy Market: Overall Company Footprint Analysis
        3.3.1 Placental Stem Cell Therapy Market: Region Footprint
        3.3.2 Placental Stem Cell Therapy Market: Company Product Type Footprint
        3.3.3 Placental Stem Cell Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Placental Stem Cell Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Placental Stem Cell Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Placental Stem Cell Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global Placental Stem Cell Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Placental Stem Cell Therapy Consumption Value by Type (2019-2030)
    6.2 North America Placental Stem Cell Therapy Consumption Value by Application (2019-2030)
    6.3 North America Placental Stem Cell Therapy Market Size by Country
        6.3.1 North America Placental Stem Cell Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico Placental Stem Cell Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Placental Stem Cell Therapy Consumption Value by Type (2019-2030)
    7.2 Europe Placental Stem Cell Therapy Consumption Value by Application (2019-2030)
    7.3 Europe Placental Stem Cell Therapy Market Size by Country
        7.3.1 Europe Placental Stem Cell Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        7.3.3 France Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy Placental Stem Cell Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Placental Stem Cell Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Placental Stem Cell Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific Placental Stem Cell Therapy Consumption Value by Region (2019-2030)
        8.3.2 China Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        8.3.5 India Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia Placental Stem Cell Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Placental Stem Cell Therapy Consumption Value by Type (2019-2030)
    9.2 South America Placental Stem Cell Therapy Consumption Value by Application (2019-2030)
    9.3 South America Placental Stem Cell Therapy Market Size by Country
        9.3.1 South America Placental Stem Cell Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina Placental Stem Cell Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Placental Stem Cell Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Placental Stem Cell Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa Placental Stem Cell Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Placental Stem Cell Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE Placental Stem Cell Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Placental Stem Cell Therapy Market Drivers
    11.2 Placental Stem Cell Therapy Market Restraints
    11.3 Placental Stem Cell Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Placental Stem Cell Therapy Industry Chain
    12.2 Placental Stem Cell Therapy Upstream Analysis
    12.3 Placental Stem Cell Therapy Midstream Analysis
    12.4 Placental Stem Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Placental Stem Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Placental Stem Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Placental Stem Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Placental Stem Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Lifebank Stem Cell Banking Company Information, Head Office, and Major Competitors
    Table 6. Lifebank Stem Cell Banking Major Business
    Table 7. Lifebank Stem Cell Banking Placental Stem Cell Therapy Product and Solutions
    Table 8. Lifebank Stem Cell Banking Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Lifebank Stem Cell Banking Recent Developments and Future Plans
    Table 10. Cynata Company Information, Head Office, and Major Competitors
    Table 11. Cynata Major Business
    Table 12. Cynata Placental Stem Cell Therapy Product and Solutions
    Table 13. Cynata Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Cynata Recent Developments and Future Plans
    Table 15. Celularity Company Information, Head Office, and Major Competitors
    Table 16. Celularity Major Business
    Table 17. Celularity Placental Stem Cell Therapy Product and Solutions
    Table 18. Celularity Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Celularity Recent Developments and Future Plans
    Table 20. Athersys Company Information, Head Office, and Major Competitors
    Table 21. Athersys Major Business
    Table 22. Athersys Placental Stem Cell Therapy Product and Solutions
    Table 23. Athersys Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Athersys Recent Developments and Future Plans
    Table 25. Americord Registry Company Information, Head Office, and Major Competitors
    Table 26. Americord Registry Major Business
    Table 27. Americord Registry Placental Stem Cell Therapy Product and Solutions
    Table 28. Americord Registry Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Americord Registry Recent Developments and Future Plans
    Table 30. ReNeuron Group Company Information, Head Office, and Major Competitors
    Table 31. ReNeuron Group Major Business
    Table 32. ReNeuron Group Placental Stem Cell Therapy Product and Solutions
    Table 33. ReNeuron Group Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. ReNeuron Group Recent Developments and Future Plans
    Table 35. ReeLabs Company Information, Head Office, and Major Competitors
    Table 36. ReeLabs Major Business
    Table 37. ReeLabs Placental Stem Cell Therapy Product and Solutions
    Table 38. ReeLabs Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. ReeLabs Recent Developments and Future Plans
    Table 40. Mesoblast Company Information, Head Office, and Major Competitors
    Table 41. Mesoblast Major Business
    Table 42. Mesoblast Placental Stem Cell Therapy Product and Solutions
    Table 43. Mesoblast Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Mesoblast Recent Developments and Future Plans
    Table 45. Pluristem Therapeutics Company Information, Head Office, and Major Competitors
    Table 46. Pluristem Therapeutics Major Business
    Table 47. Pluristem Therapeutics Placental Stem Cell Therapy Product and Solutions
    Table 48. Pluristem Therapeutics Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Pluristem Therapeutics Recent Developments and Future Plans
    Table 50. Global Placental Stem Cell Therapy Revenue (USD Million) by Players (2019-2024)
    Table 51. Global Placental Stem Cell Therapy Revenue Share by Players (2019-2024)
    Table 52. Breakdown of Placental Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 53. Market Position of Players in Placental Stem Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 54. Head Office of Key Placental Stem Cell Therapy Players
    Table 55. Placental Stem Cell Therapy Market: Company Product Type Footprint
    Table 56. Placental Stem Cell Therapy Market: Company Product Application Footprint
    Table 57. Placental Stem Cell Therapy New Market Entrants and Barriers to Market Entry
    Table 58. Placental Stem Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 59. Global Placental Stem Cell Therapy Consumption Value (USD Million) by Type (2019-2024)
    Table 60. Global Placental Stem Cell Therapy Consumption Value Share by Type (2019-2024)
    Table 61. Global Placental Stem Cell Therapy Consumption Value Forecast by Type (2025-2030)
    Table 62. Global Placental Stem Cell Therapy Consumption Value by Application (2019-2024)
    Table 63. Global Placental Stem Cell Therapy Consumption Value Forecast by Application (2025-2030)
    Table 64. North America Placental Stem Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 65. North America Placental Stem Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 66. North America Placental Stem Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 67. North America Placental Stem Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 68. North America Placental Stem Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 69. North America Placental Stem Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 70. Europe Placental Stem Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 71. Europe Placental Stem Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 72. Europe Placental Stem Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 73. Europe Placental Stem Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 74. Europe Placental Stem Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 75. Europe Placental Stem Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 76. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 77. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 78. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 79. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 80. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 81. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 82. South America Placental Stem Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 83. South America Placental Stem Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 84. South America Placental Stem Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 85. South America Placental Stem Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 86. South America Placental Stem Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 87. South America Placental Stem Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 88. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 89. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 90. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 91. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 92. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 93. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 94. Placental Stem Cell Therapy Raw Material
    Table 95. Key Suppliers of Placental Stem Cell Therapy Raw Materials
List of Figures
    Figure 1. Placental Stem Cell Therapy Picture
    Figure 2. Global Placental Stem Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Placental Stem Cell Therapy Consumption Value Market Share by Type in 2023
    Figure 4. Hematologic Malignancies and Disorders
    Figure 5. Congenital Immunodeficiency Disorders
    Figure 6. Metabolic Disorders
    Figure 7. Neurological Disorders
    Figure 8. Others
    Figure 9. Global Placental Stem Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 10. Placental Stem Cell Therapy Consumption Value Market Share by Application in 2023
    Figure 11. Hospitals and Specialty Clinics Picture
    Figure 12. Clinical Research Organizations Picture
    Figure 13. Research Institutes and Academies Picture
    Figure 14. Others Picture
    Figure 15. Global Placental Stem Cell Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 16. Global Placental Stem Cell Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 17. Global Market Placental Stem Cell Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 18. Global Placental Stem Cell Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 19. Global Placental Stem Cell Therapy Consumption Value Market Share by Region in 2023
    Figure 20. North America Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 21. Europe Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 22. Asia-Pacific Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 23. South America Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 24. Middle East and Africa Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 25. Global Placental Stem Cell Therapy Revenue Share by Players in 2023
    Figure 26. Placental Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 27. Global Top 3 Players Placental Stem Cell Therapy Market Share in 2023
    Figure 28. Global Top 6 Players Placental Stem Cell Therapy Market Share in 2023
    Figure 29. Global Placental Stem Cell Therapy Consumption Value Share by Type (2019-2024)
    Figure 30. Global Placental Stem Cell Therapy Market Share Forecast by Type (2025-2030)
    Figure 31. Global Placental Stem Cell Therapy Consumption Value Share by Application (2019-2024)
    Figure 32. Global Placental Stem Cell Therapy Market Share Forecast by Application (2025-2030)
    Figure 33. North America Placental Stem Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 34. North America Placental Stem Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 35. North America Placental Stem Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 37. Canada Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 38. Mexico Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 39. Europe Placental Stem Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 40. Europe Placental Stem Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 41. Europe Placental Stem Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 42. Germany Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 43. France Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 44. United Kingdom Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 45. Russia Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 46. Italy Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 47. Asia-Pacific Placental Stem Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 48. Asia-Pacific Placental Stem Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 49. Asia-Pacific Placental Stem Cell Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 50. China Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 51. Japan Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 52. South Korea Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 53. India Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 54. Southeast Asia Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 55. Australia Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 56. South America Placental Stem Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 57. South America Placental Stem Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 58. South America Placental Stem Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 59. Brazil Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 60. Argentina Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 61. Middle East and Africa Placental Stem Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 62. Middle East and Africa Placental Stem Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 63. Middle East and Africa Placental Stem Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 64. Turkey Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 65. Saudi Arabia Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 66. UAE Placental Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 67. Placental Stem Cell Therapy Market Drivers
    Figure 68. Placental Stem Cell Therapy Market Restraints
    Figure 69. Placental Stem Cell Therapy Market Trends
    Figure 70. Porters Five Forces Analysis
    Figure 71. Manufacturing Cost Structure Analysis of Placental Stem Cell Therapy in 2023
    Figure 72. Manufacturing Process Analysis of Placental Stem Cell Therapy
    Figure 73. Placental Stem Cell Therapy Industrial Chain
    Figure 74. Methodology
    Figure 75. Research Process and Data Source

Companies Mentioned

Lifebank Stem Cell Banking
Cynata
Celularity
Athersys
Americord Registry
ReNeuron Group
ReeLabs
Mesoblast
Pluristem Therapeutics